| Oct 29 |
Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance
|
| Oct 29 |
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates
|
| Oct 29 |
GeneDx GAAP EPS of -$0.31 beats by $0.13, revenue of $76.88M beats by $11.89M
|
| Oct 29 |
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
|
| Oct 28 |
GeneDx Q3 2024 Earnings Preview
|
| Oct 25 |
GeneDx reveals new findings from newborn genetic screening study
|
| Oct 24 |
Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
|
| Oct 21 |
GeneDx Holdings: Stock To Keep Outperforming As Business Momentum Persists
|
| Oct 9 |
GeneDx Holdings Corp (WGS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...
|
| Oct 8 |
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
|
